177 related articles for article (PubMed ID: 6166477)
1. Influence of plasma protease inhibitors and Trasylol on trypsin-induced bradykinin-release in vitro and in vivo. Protease inhibitors and trypsin-induced bradykinin release.
Balldin G; Gustafsson EL; Ohlsson K
Eur Surg Res; 1980; 12(4):260-9. PubMed ID: 6166477
[TBL] [Abstract][Full Text] [Related]
2. Trasylol prevents trypsin-induced shock in dogs.
Balldin G; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1979 May; 360(5):651-6. PubMed ID: 89067
[TBL] [Abstract][Full Text] [Related]
3. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man.
Lasson A; Dittmann B; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1315-22. PubMed ID: 6195066
[TBL] [Abstract][Full Text] [Related]
4. An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum.
Lasson A; Ohlsson K
Biochim Biophys Acta; 1982 Dec; 709(2):227-33. PubMed ID: 6185150
[TBL] [Abstract][Full Text] [Related]
5. Studies on the influence of Trasylol on the partition of trypsin between the human plasma protease inhibitors in vitro.
Balldin G; Ohlsson K; Olsson AS
Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):691-7. PubMed ID: 307526
[TBL] [Abstract][Full Text] [Related]
6. Trypsin-induced release of bradykinin and of C3 fragments in man: clinical and experimental studies on the protective role of alpha 2-macroglobulin and aprotinin.
Ohlsson F; Balldin G; Lasson A
Adv Exp Med Biol; 1983; 156 (Pt B)():1083-90. PubMed ID: 6190382
[No Abstract] [Full Text] [Related]
7. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
Marks WH; Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
[TBL] [Abstract][Full Text] [Related]
8. Interactions in vitro and in vivo between rat serum protease inhibitors and anodal and cathodal rat trypsin and chymotrypsin.
Gauthier F; Genell S; Mouray H; Ohlsson K
Biochim Biophys Acta; 1979 Jan; 566(1):200-10. PubMed ID: 83164
[TBL] [Abstract][Full Text] [Related]
9. [Uniform method for determining the alpha 1-antitrypsin and alpha 2-macroglobulin activity in human blood serum (plasma)].
Nartikova VF; Paskhina TS
Vopr Med Khim; 1979; 25(4):494-9. PubMed ID: 89758
[TBL] [Abstract][Full Text] [Related]
10. [Antiproteinase activity of alpha 2-macroglobulin].
Protsenko AV
Ukr Biokhim Zh (1978); 1984; 56(5):546-9. PubMed ID: 6209837
[TBL] [Abstract][Full Text] [Related]
11. Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationship with metabolic control.
Finotti P; Piccoli A; Carraro P
Diabetes Res Clin Pract; 1992 Oct; 18(1):35-42. PubMed ID: 1280191
[TBL] [Abstract][Full Text] [Related]
12. Concentration of some proteinase inhibitors: alpha 1-antitrypsin and alpha 2-macroglobulin in rabbit blood serum in two models of experimental atherosclerosis.
Grabowska-Bochenek R; Drózdz M; Kopieczna-Grzebieniak E; Piekarski M
Acta Biochim Pol; 1990; 37(1):125-7. PubMed ID: 1708185
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitors of proteolytic enzymes in the blood serum of patients with diphyllobothriasis].
Gosteva LA
Med Parazitol (Mosk); 1990; (4):29-31. PubMed ID: 1700263
[TBL] [Abstract][Full Text] [Related]
14. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
[TBL] [Abstract][Full Text] [Related]
15. The elimination in dogs of trypsin-alpha-macroglobulin complexes inactivated by the Kazal or the Kunitz inhibitor.
Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1978 Mar; 359(3):379-84. PubMed ID: 76602
[TBL] [Abstract][Full Text] [Related]
16. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
Lasson A; Ohlsson K
Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
[TBL] [Abstract][Full Text] [Related]
17. Plasma proteinases, proteinase inhibitors and other selective plasma proteins following aortofemoral bypass operation.
Hörl M; Sperling M; Mayer J; Hörl WH
Eur Surg Res; 1986; 18(2):69-79. PubMed ID: 2423335
[TBL] [Abstract][Full Text] [Related]
18. Alpha 2 macroglobulin and the protease-inhibitory activity of colloid pancreatic preservation solutions.
Donnelly PK; Edwards C; Condie R
Transplant Proc; 1990 Apr; 22(2):535-6. PubMed ID: 1691543
[No Abstract] [Full Text] [Related]
19. Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis.
Durie PR; Gaskin KJ; Ogilvie JE; Smith CR; Forstner GG; Largman C
J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):199-207. PubMed ID: 2580962
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic enzyme activity in patients with severe head injury and the effect of a proteinase inhibitor.
Auer LM; Marth E; Heppner F; Holasek A
Acta Neurochir (Wien); 1979; 49(3-4):207-17. PubMed ID: 92877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
